The EVERY Company has secured $55 million in funding to scale up production of their precision-fermented egg proteins, such as OvoPro and OvoBoost. This investment will support the company's expansion into the US market and increase their presence in sectors like baked goods, beverages, and protein supplements. By offering a stable and reliable source of animal-free protein, EVERY is addressing issues in traditional egg production, such as disease outbreaks and environmental concerns.

In addition to launching their proteins in Walmart stores across the US, EVERY is gaining recognition for their fermentation-based technology as a game-changer in the food industry. With support from investors like McWin Capital Partners, Main Sequence, and prominent figures like Anne Hathaway, EVERY is proving that biomanufacturing has the potential to transform the food industry by providing scalable and sustainable solutions to supply chain challenges.